6QD9
Leishmania major N-myristoyltransferase in complex with thienopyrimidine inhibitor IMP-0000065
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-12-02 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.9795 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 47.720, 90.780, 53.030 |
Unit cell angles | 90.00, 111.92, 90.00 |
Refinement procedure
Resolution | 37.740 - 1.460 |
R-factor | 0.16802 |
Rwork | 0.166 |
R-free | 0.20017 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 4cgp |
RMSD bond length | 0.012 |
RMSD bond angle | 2.031 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | REFMAC |
Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 45.000 | 1.500 |
High resolution limit [Å] | 1.460 | 1.460 |
Rmerge | 0.054 | 0.510 |
Number of reflections | 70913 | |
<I/σ(I)> | 14.3 | 2.1 |
Completeness [%] | 97.7 | 87.9 |
Redundancy | 4.1 | 3.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 291 | 30% PEG 1500, 0.2 M NACL, 0.1 M NA CACODYLATE, PH 5.5 |